Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis.
Saved in:
| Title: | Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis. |
|---|---|
| Authors: | Lundblad MS; Novo Nordisk A/S, Søborg, Denmark, mslu@novonordisk.com., Overgaard RV, Göthberg M, Fjording MS, Watson E |
| Source: | Advances in therapy [Adv Ther] 2015 Mar; Vol. 32 (3), pp. 228-38. Date of Electronic Publication: 2015 Mar 07. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25749867 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lundblad+MS%22">Lundblad MS</searchLink>; Novo Nordisk A/S, Søborg, Denmark, mslu@novonordisk.com.<br /><searchLink fieldCode="AU" term="%22Overgaard+RV%22">Overgaard RV</searchLink><br /><searchLink fieldCode="AU" term="%22Göthberg+M%22">Göthberg M</searchLink><br /><searchLink fieldCode="AU" term="%22Fjording+MS%22">Fjording MS</searchLink><br /><searchLink fieldCode="AU" term="%22Watson+E%22">Watson E</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2015 Mar; Vol. 32 (3), pp. 228-38. <i>Date of Electronic Publication: </i>2015 Mar 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25749867 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s12325-015-0191-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 228 Titles: – TitleFull: Clinical pharmacokinetics of the anti-interleukin-20 monoclonal antibody NNC0109-0012 in healthy volunteers and patients with psoriasis or rheumatoid arthritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lundblad MS – PersonEntity: Name: NameFull: Overgaard RV – PersonEntity: Name: NameFull: Göthberg M – PersonEntity: Name: NameFull: Fjording MS – PersonEntity: Name: NameFull: Watson E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2015 Mar Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1865-8652 Numbering: – Type: volume Value: 32 – Type: issue Value: 3 Titles: – TitleFull: Advances in therapy Type: main |
| ResultId | 1 |
